Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
Rhea-AI Summary
Evolent Health (NYSE: EVH) has announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025. Dr. Nguyen, who joined Evolent as Chief Clinical Officer in July 2024, brings experience from Google's population health division, Blue Cross North Carolina, CDC, and CMS. He will succeed Dr. Andrew Hertler, who will transition to a part-time role as senior advisor and CMO emeritus after more than a decade with the company.
Dr. Nguyen's background includes roles in patient care, health policy, and clinical innovation. He previously helped design value-based programs in specialty and primary care at CMS and has worked in clinics serving underserved communities. Dr. Hertler, a medical oncologist with over 40 years of experience, will continue to focus on advancing innovation for Evolent's oncology management solution.
Positive
- Appointment of experienced healthcare executive Dr. Von Nguyen with significant background in population health and value-based care
- Retention of former CMO Dr. Hertler in advisory capacity maintaining continuity in oncology management
Negative
- None.
News Market Reaction – EVH
In the trading session that priced this news, EVH gained 4.39%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus.
Dr. Nguyen joined Evolent as Chief Clinical Officer in July 2024 after serving as clinical lead for population health at Google. Among other previous roles, he has been Chief Medical Officer at Blue Cross North Carolina, Deputy Associate Director of Policy and Strategy at the Centers for Disease Control and Prevention, and Senior Advisor at the Centers for Medicare and Medicaid Services, where he helped design value-based programs in specialty and primary care. Trained as a primary care physician, he has worked at clinics for underserved communities in the
"Dr. Nguyen's unique mix of experiences in delivering patient care, shaping health policy and powering clinical innovation at scale position him well to lead Evolent's own clinical quality programs," said Evolent President Dan McCarthy. "As he has already demonstrated in his short time here, Von's background and skills, combined with his profound empathy for patients and his relentless passion for bringing fresh solutions to status quo challenges, will accelerate our efforts to create a higher-quality, more affordable and less fragmented healthcare system."
Dr. Nguyen will succeed Dr. Andrew Hertler, who will move to a part-time role as senior advisor and CMO emeritus after more than a decade at Evolent. Dr. Hertler, a medical oncologist with more than 40 years in the field, will focus on advancing innovation for Evolent's oncology management solution.
"Dr. Hertler is a giant in the field of value-based specialty care and improving patient outcomes, and I am honored to succeed him," said Dr. Nguyen. "I came to Evolent to help accelerate our mission of making care simpler, higher quality, more affordable and more connected for patients dealing with complex health conditions. Our team of over 1,500 doctors, nurses and allied clinicians wake up every day focused on this mission, and I look forward to working with them in my new role to build on Dr. Hertler's strong legacy in the future."
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in healthcare nationally. Learn more about how Evolent is changing the way healthcare is delivered by visiting evolent.com.
Contacts
Media: Jamie Manfuso, media@evolent.com
Investors: Seth R. Frank, sfrank@evolent.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-announces-dr-von-nguyen-as-incoming-chief-medical-officer-effective-january-1-302335408.html
SOURCE Evolent Health, Inc.